Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Skin
The skin lesions follow Blaschko’s lines and progress through a characteristic sequence. In human IP, four stages are described (vesicular, verrucous, hyperpigmented, hypopigmented-atrophic). The equine presentation shows analogous stages: inflammatory and hyperpigmented phases producing the visible striping, with the patterning following the developmental migration paths of skin cells. The stripe pattern in IP-affected mares is, visually, indistinguishable from other forms of brindle in the field. [Towers et al. 2013]
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Clinical presentation
Incontinentia pigmenti in affected mares presents across multiple organ systems. The skin findings are the most visible, but they are not the only findings.
Skin
The skin lesions follow Blaschko’s lines and progress through a characteristic sequence. In human IP, four stages are described (vesicular, verrucous, hyperpigmented, hypopigmented-atrophic). The equine presentation shows analogous stages: inflammatory and hyperpigmented phases producing the visible striping, with the patterning following the developmental migration paths of skin cells. The stripe pattern in IP-affected mares is, visually, indistinguishable from other forms of brindle in the field. [Towers et al. 2013]
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
Inheritance pattern
IKBKG maps to the X chromosome. Incontinentia pigmenti in horses follows an X-linked dominant pattern with lethality in hemizygous males. This is the same inheritance architecture as the human form of incontinentia pigmenti (OMIM:308300), which has been studied extensively.
In heterozygous mares (one mutant IKBKG allele, one normal allele), X-inactivation creates a mosaic of cells with functional IKBKG signaling and cells without it. This mosaic maps onto Blaschko’s lines, producing the striped skin presentation. Cells relying on the non-functional copy are at a disadvantage; the NF-kB signaling failure triggers apoptosis and compensatory inflammation, which progresses through the clinical stages described below.
Hemizygous males (a single mutant IKBKG allele, no balancing copy) are typically lethal in utero. The complete absence of functional IKBKG signaling is incompatible with normal embryonic development. This lethality pattern produces a characteristic distortion in the sex ratio of offspring from affected mares: fewer males than expected. [Towers et al. 2013]
Clinical presentation
Incontinentia pigmenti in affected mares presents across multiple organ systems. The skin findings are the most visible, but they are not the only findings.
Skin
The skin lesions follow Blaschko’s lines and progress through a characteristic sequence. In human IP, four stages are described (vesicular, verrucous, hyperpigmented, hypopigmented-atrophic). The equine presentation shows analogous stages: inflammatory and hyperpigmented phases producing the visible striping, with the patterning following the developmental migration paths of skin cells. The stripe pattern in IP-affected mares is, visually, indistinguishable from other forms of brindle in the field. [Towers et al. 2013]
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
The 2013 study
The foundational paper is Towers et al., published in PLOS ONE in 2013: “Equine Incontinentia Pigmenti — A Hamartomatous Disorder Caused by Dominant IKBKG Mutations.” [Towers et al., PLOS ONE, 2013, doi:10.1371/journal.pone.0081625] The study investigated a family of American Quarter Horses presenting with brindle-like patterning and systemic abnormalities, identified the causative mutation, and characterized the inheritance pattern.
The causative variant is a nonsense mutation in the IKBKG gene: c.184C>T, producing a premature stop codon at p.Arg62* (arginine to stop). This variant was found in affected mares in the family and was absent from unaffected controls. The IKBKG gene encodes the regulatory subunit of the IKK complex, which is central to the NF-kB signaling pathway — a major regulator of immune response, cell survival, and development. [Towers et al. 2013; OMIA:001899-9796]
The OMIA record for equine incontinentia pigmenti is catalogued as OMIA:001899-9796 for Equus caballus.
Inheritance pattern
IKBKG maps to the X chromosome. Incontinentia pigmenti in horses follows an X-linked dominant pattern with lethality in hemizygous males. This is the same inheritance architecture as the human form of incontinentia pigmenti (OMIM:308300), which has been studied extensively.
In heterozygous mares (one mutant IKBKG allele, one normal allele), X-inactivation creates a mosaic of cells with functional IKBKG signaling and cells without it. This mosaic maps onto Blaschko’s lines, producing the striped skin presentation. Cells relying on the non-functional copy are at a disadvantage; the NF-kB signaling failure triggers apoptosis and compensatory inflammation, which progresses through the clinical stages described below.
Hemizygous males (a single mutant IKBKG allele, no balancing copy) are typically lethal in utero. The complete absence of functional IKBKG signaling is incompatible with normal embryonic development. This lethality pattern produces a characteristic distortion in the sex ratio of offspring from affected mares: fewer males than expected. [Towers et al. 2013]
Clinical presentation
Incontinentia pigmenti in affected mares presents across multiple organ systems. The skin findings are the most visible, but they are not the only findings.
Skin
The skin lesions follow Blaschko’s lines and progress through a characteristic sequence. In human IP, four stages are described (vesicular, verrucous, hyperpigmented, hypopigmented-atrophic). The equine presentation shows analogous stages: inflammatory and hyperpigmented phases producing the visible striping, with the patterning following the developmental migration paths of skin cells. The stripe pattern in IP-affected mares is, visually, indistinguishable from other forms of brindle in the field. [Towers et al. 2013]
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site
A brindle-looking mare with dental abnormalities, abnormal hoof growth, and progressive skin lesions is not simply an unusual coat pattern. She may have incontinentia pigmenti — a systemic genetic disorder that produces the same Blaschko-line striping as other forms of brindle but originates from a disease gene rather than a coat-color gene. The distinction matters clinically: a BR1 brindle mare has a coat variant with no known health consequence; an IP-affected mare has a condition that involves multiple organ systems and may have implications for her offspring.
Incontinentia pigmenti in horses was first characterized in a peer-reviewed study in 2013. The gene, the variant, the inheritance pattern, and the clinical signs are now documented. What is not always documented, in the literature or in breeding records, is that this diagnosis exists — that brindle-like striping in mares occasionally signals a systemic disorder rather than a coat anomaly.
The 2013 study
The foundational paper is Towers et al., published in PLOS ONE in 2013: “Equine Incontinentia Pigmenti — A Hamartomatous Disorder Caused by Dominant IKBKG Mutations.” [Towers et al., PLOS ONE, 2013, doi:10.1371/journal.pone.0081625] The study investigated a family of American Quarter Horses presenting with brindle-like patterning and systemic abnormalities, identified the causative mutation, and characterized the inheritance pattern.
The causative variant is a nonsense mutation in the IKBKG gene: c.184C>T, producing a premature stop codon at p.Arg62* (arginine to stop). This variant was found in affected mares in the family and was absent from unaffected controls. The IKBKG gene encodes the regulatory subunit of the IKK complex, which is central to the NF-kB signaling pathway — a major regulator of immune response, cell survival, and development. [Towers et al. 2013; OMIA:001899-9796]
The OMIA record for equine incontinentia pigmenti is catalogued as OMIA:001899-9796 for Equus caballus.
Inheritance pattern
IKBKG maps to the X chromosome. Incontinentia pigmenti in horses follows an X-linked dominant pattern with lethality in hemizygous males. This is the same inheritance architecture as the human form of incontinentia pigmenti (OMIM:308300), which has been studied extensively.
In heterozygous mares (one mutant IKBKG allele, one normal allele), X-inactivation creates a mosaic of cells with functional IKBKG signaling and cells without it. This mosaic maps onto Blaschko’s lines, producing the striped skin presentation. Cells relying on the non-functional copy are at a disadvantage; the NF-kB signaling failure triggers apoptosis and compensatory inflammation, which progresses through the clinical stages described below.
Hemizygous males (a single mutant IKBKG allele, no balancing copy) are typically lethal in utero. The complete absence of functional IKBKG signaling is incompatible with normal embryonic development. This lethality pattern produces a characteristic distortion in the sex ratio of offspring from affected mares: fewer males than expected. [Towers et al. 2013]
Clinical presentation
Incontinentia pigmenti in affected mares presents across multiple organ systems. The skin findings are the most visible, but they are not the only findings.
Skin
The skin lesions follow Blaschko’s lines and progress through a characteristic sequence. In human IP, four stages are described (vesicular, verrucous, hyperpigmented, hypopigmented-atrophic). The equine presentation shows analogous stages: inflammatory and hyperpigmented phases producing the visible striping, with the patterning following the developmental migration paths of skin cells. The stripe pattern in IP-affected mares is, visually, indistinguishable from other forms of brindle in the field. [Towers et al. 2013]
Teeth
Dental abnormalities are a documented feature of IP-affected mares. Affected horses show abnormal tooth morphology consistent with the ectodermal involvement expected from loss of IKBKG function in ectodermal cells. Teeth, hair, and sweat glands all derive from ectoderm; NF-kB signaling is required for normal ectodermal development. Dental anomalies in a brindle-patterned mare are a clinical flag for IP as opposed to the coat-only BR1 variant. [Towers et al. 2013]
Hooves
Abnormal hoof structure or growth has also been noted in IP-affected horses. The hoof wall derives from epidermis; the same ectodermal signaling disruption that affects skin and teeth also affects hoof development in a subset of affected animals. [Towers et al. 2013]
The same Quarter Horse family: BR1 and IP together
The Quarter Horse family in which IP was identified overlapped with the family in which the BR1 variant was subsequently studied. The 2016 Murgiano et al. study, which resolved the heritable brindle (BR1) to an MBTPS2 intronic variant, examined horses from the same extended pedigree and explicitly distinguished BR1-affected horses from IP-affected horses. The two conditions produce visually similar stripe patterns, follow the same Blaschko-line geometry, and are both X-linked — but they are caused by variants in different genes, with entirely different functional consequences. [Murgiano et al., G3, 2016, doi:10.1534/g3.116.032433]
This makes the Quarter Horse brindle family one of the most analytically rich cases in equine coat genetics: two distinct X-linked mechanisms, both producing brindle-like patterning via mosaicism, segregating in the same pedigree. Separating them required molecular characterization of both variants.
Distinguishing IP from BR1 and from non-heritable brindle
Three findings, taken together, distinguish an IP-affected mare from a BR1 or chimeric/mosaic brindle:
- Multi-system pathology. IP-affected mares have findings beyond the coat. Dental abnormalities, hoof anomalies, or skin lesion progression (not just stable striping) in a brindle-patterned mare raises the probability of IP over BR1. A BR1 mare has no reported systemic pathology. A chimeric or mosaic brindle also has no systemic pathology from the brindle mechanism itself.
- Skewed offspring sex ratio. An IP mare producing fewer males than expected — particularly if male fetuses or foals are lost — reflects the hemizygous-lethal effect. This pattern is not seen in BR1 families.
- Genetic testing. The IKBKG c.184C>T variant is specific to IP. The MBTPS2 c.1437+4T>C variant is specific to BR1. A laboratory can distinguish them directly. The UC Davis Veterinary Genetics Laboratory offers the BR1 test (vgl.ucdavis.edu); targeted IKBKG sequencing can identify the IP variant. [OMIA:001899-9796; OMIA:002021-9796]
The visual stripe pattern alone cannot make this distinction. That is the central clinical point. A brindle Quarter Horse mare with concurrent health findings is not simply “an unusual color” — she may carry a pathogenic variant with implications for her offspring and her own long-term health. The correct evaluation includes a physical examination that looks beyond the coat.
Human IP and the shared gene
Human incontinentia pigmenti (OMIM:308300) is caused by mutations in the same gene — IKBKG (also called NEMO) — and follows the same X-linked dominant, male-lethal inheritance pattern. Human IP is well-characterized, with a literature spanning several decades. The cutaneous manifestations follow Blaschko’s lines; the systemic manifestations include dental, ophthalmologic, neurologic, and hair findings. The equine and human conditions share a genetic basis and an inheritance mechanism; they differ in which tissues are most prominently affected by the signaling disruption. [Smahi et al., Nature, 2000, doi:10.1038/35073574]
The human literature provides the mechanistic framework for interpreting the equine condition. NF-kB signaling, downstream of the IKK complex in which IKBKG is a regulatory subunit, is required for the survival of cells that cannot tolerate its absence. In a mosaic female, cells with a non-functional IKBKG allele active are at a survival disadvantage; over time, the mosaic shifts toward cells with the functional allele, which can suppress the inflammatory phases and produce the hypopigmented late-stage presentation. The equine disease follows the same general logic.
Summary
Incontinentia pigmenti in horses is a real, genetically characterized condition caused by a specific variant in IKBKG (c.184C>T, p.Arg62*), confirmed in American Quarter Horses and catalogued as OMIA:001899-9796. It produces brindle-like striping that is visually indistinguishable from the BR1 coat variant or from chimerism and somatic mosaicism, but accompanies systemic pathology that the other mechanisms do not produce. The inheritance pattern is X-linked dominant with hemizygous male lethality.
A brindle-patterned mare should be evaluated as a coat variant unless she also presents with dental, hoof, or skin lesion findings — at which point the differential includes IP, and genetic testing can confirm or exclude the specific IKBKG variant.
Related reading on this site